Clinical Trials Browser

INDUSTRY × Melanoma × EBC-46 × Clear all

NCT05234437 2023-04-19

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

Phase 2 Terminated

Melanoma

NCT04834973 2023-04-18

A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma

Phase 1/2 Terminated

Melanoma